Literature DB >> 31886580

The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma.

Guo-Tian Ruan1, Li-Chen Zhu2, Yi-Zhen Gong1, Xi-Wen Liao3, Xiang-Kun Wang3, Cun Liao1, Shuai Wang1, Ling Yan1, Hai-Lun Xie1, Xin Zhou3, Yang-Zi Li4, Feng Gao1.   

Abstract

WNT family genes have participated in the progression and development of many cancers, however, the association between colon adenocarcinoma (COAD) and WNTs have been rarely reported. This study investigated the significance of WNT genes expression in COAD from the standpoint of diagnosis and prognosis. The RNA-sequencing dataset of COAD was downloaded from The Cancer Genome Atlas and University of California, Santa Cruz Xena browser. The biology functions of WNT genes were investigated by biological analysis. Biological analysis of WNT family genes indicated that WNT genes were noticeably enriched in the complex process of WNT signaling pathway. The Pearson correlation analysis suggested WNT1 and WNT9B had a strong correlation. And receiver operating characteristic curves suggested that most of the genes could serve as a significant diagnostic makers in COAD (P < .05), especially WNT2 and WNT7B had high diagnostic values that the area under curve were 0.997 (95% confidence interval [0.994-1.000]) and 0.961 (95%CI [0.939-0.983]), respectively. And our multivariate survival analysis suggested the downregulated of WNT10B (P < .05) showed a favor prognosis in COAD overall survival. And the risk score model predicted that the upregulated expression of WNT10B might increase the risk of death. The very study we had conducted suggested that WNT genes had a certain connection with the diagnosis and prognosis of COAD. The messenger RNA expression of WNT2 and WNT7B might become potentially diagnostic biomarkers, and WNT10B might serve as an independent prognosis indicator for COAD.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  WNT; colon adenocarcinoma; diagnosis; mRNA; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31886580     DOI: 10.1002/jcb.29582

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Characterization of exosomal long non-coding RNAs in chondrogenic differentiation of human adipose-derived stem cells.

Authors:  Ziji Zhang; Guangxin Huang; Guping Mao; Shu Hu
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

2.  Plasma-derived extracellular vesicles transfer microRNA-130a-3p to alleviate myocardial ischemia/reperfusion injury by targeting ATG16L1.

Authors:  Sisi Yu; Xuepei Tang; Tian Zheng; Shuhao Li; Haibo Ren; Hailong Wu; Fei Peng; Lianggeng Gong
Journal:  Cell Tissue Res       Date:  2022-05-03       Impact factor: 5.249

3.  PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.

Authors:  Jing Li; Wei-Min Kong
Journal:  J Immunol Res       Date:  2022-04-20       Impact factor: 4.493

4.  Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis.

Authors:  Shuai Jiang; Qiwen Li; Yimin Liu; Huimin Zhang; Qianyu Wang; Yu Chen; Xiaoyang Shi; Jun Li; Hailing Zhang; Yi Zhang; Dongqing Xia; Man Wu; Jiajia Lin; Chenglin Zhang; Suhua Pang; Jiamin Jiang; Yan Wen; Peipei Zhang
Journal:  BMC Cancer       Date:  2021-02-19       Impact factor: 4.430

5.  Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.

Authors:  Guo-Tian Ruan; Hai-Lun Xie; Li-Chen Zhu; Yi-Zhong Ge; Lin Yan; Cun Liao; Yi-Zhen Gong; Han-Ping Shi
Journal:  Front Genet       Date:  2022-02-08       Impact factor: 4.599

6.  A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.

Authors:  Le Liu; Liping Liang; Genghui Mai; Ye Chen
Journal:  FASEB Bioadv       Date:  2022-06-13

7.  Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts.

Authors:  Sunyoung Park; Sungwoo Ahn; Jee Ye Kim; Jungho Kim; Hyun Ju Han; Dasom Hwang; Jungmin Park; Hyung Seok Park; Seho Park; Gun Min Kim; Joohyuk Sohn; Joon Jeong; Yong Uk Song; Hyeyoung Lee; Seung Il Kim
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

8.  SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis.

Authors:  Fu-Ren Yue; Zhi-Bin Wei; Rui-Zhen Yan; Qiu-Hong Guo; Bing Liu; Jing-Hui Zhang; Zheng Li
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.